3-[3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethylpyrazol-4-yl)-2-oxo-4H-pyrido[4,3-d]pyrimidin-1-yl]benzonitrile
C27H22F2N6O3 — CID 122474361
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethylpyrazol-4-yl)-2-oxo-4H-pyrido[4,3-d]pyrimidin-1-yl]benzonitrile
3-[3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethylpyrazol-4-yl)-2-oxo-4H-pyrido[4,3-d]pyrimidin-1-yl]benzonitrile (PubChem CID 122474361) has the molecular formula C27H22F2N6O3 and a molecular weight of 516.51 g/mol. Its IUPAC name is 3-[3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethylpyrazol-4-yl)-2-oxo-4H-pyrido[4,3-d]pyrimidin-1-yl]benzonitrile.
Molecular Properties
| Compound Name | 3-[3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethylpyrazol-4-yl)-2-oxo-4H-pyrido[4,3-d]pyrimidin-1-yl]benzonitrile |
|---|---|
| PubChem CID | 122474361 |
| Molecular Formula | C27H22F2N6O3 |
| Molecular Weight | 516.51 g/mol |
| Exact Mass | 516.17 |
| IUPAC Name | 3-[3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethylpyrazol-4-yl)-2-oxo-4H-pyrido[4,3-d]pyrimidin-1-yl]benzonitrile |
| SMILES | COc1cc(OC)c(F)c(N2Cc3cnc(-c4cn(C)nc4C)cc3N(c3cccc(C#N)c3)C2=O)c1F |
| InChI | InChI=1S/C27H22F2N6O3/c1-15-19(14-33(2)32-15)20-9-21-17(12-31-20)13-34(26-24(28)22(37-3)10-23(38-4)25(26)29)27(36)35(21)18-7-5-6-16(8-18)11-30/h5-10,12,14H,13H2,1-4H3 |
| InChIKey | MSYUMSMBBQJIFX-UHFFFAOYSA-N |
| XLogP | 5.24 |
| TPSA | 96.51 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 516.51 |
| LogP ≤ 5 | 5.24 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122474361 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.